Christopher Ogden Cytom X Therapeutics, Inc. (CTMX) insider trading activity
Christopher Ogden is Chief Financial Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 103,186 shares of CTMX, which is worth approximately $139,301. The most recent transaction as insider was on Jun 12, 2024, when has been sold 17,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
103K
20.42%
3M change
173.18%
12M change
Total Value Held
$139,301
Christopher Ogden Transaction History
CO
Christopher Ogden
Chief Financial Officer
South San Francisco, CA